Regenerex Pharma (RGPX) Cash from Discontinued Operations (2021 - 2022)

Regenerex Pharma (RGPX) reported Cash from Discontinued Operations of 3248.0 for Q1 2022, up 418.12% quarter-over-quarter from 1021.0 in Q4 2021.

Regenerex Pharma (RGPX) Cash from Discontinued Operations (2021 - 2022) Analysis & Trends

Regenerex Pharma (RGPX) has 2 years of Cash from Discontinued Operations data on file, last reported at 3248.0 in Q1 2022.

Cash from Discontinued Operations for Q1 2022 came in at 3248.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was 5510.0 (changed N/A YoY), and the FY2022 annual result was 5510.0, changed N/A from the prior year.
Cash from Discontinued Operations climbed to 3248.0 in Q1 2022 per RGPX's latest filing, from 1021.0 in the prior quarter.
Over five years, Cash from Discontinued Operations peaked at 3248.0 in Q1 2022 and troughed at 5275.0 in Q2 2021.

Download Data